We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

252 hedge funds and large institutions have $3.49B invested in Charles River Laboratories in 2014 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 77 increasing their positions, 109 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

115% more call options, than puts

Call options by funds: $999K | Put options by funds: $464K

26% more capital invested

Capital invested by funds: $2.77B → $3.49B (+$714M)

8% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 24

1% less funds holding

Funds holding: 255 → 252 (-3)

1.43% less ownership

Funds ownership: 100.05% → 98.62% (-1.4%)

29% less repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 109

33% less funds holding in top 10

Funds holding in top 10: 6 → 4 (-2)

Holders
252
Holders Change
-3
Holders Change %
-1.18%
% of All Funds
6.72%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.11%
New
26
Increased
77
Reduced
109
Closed
24
Calls
$999K
Puts
$464K
Net Calls
+$535K
Net Calls Change
-$5.16M

Top Buyers

1
First Trust Advisors
First Trust Advisors
Illinois
+$77.7M
2
Victory Capital Management
Victory Capital Management
Texas
+$18.6M
3
CIP
Chartwell Investment Partners
Pennsylvania
+$16.5M
4
PM
Pembroke Management
Quebec, Canada
+$12.6M
5
QI
QS Investors
New York
+$11.3M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$16.6M
2
RIM
RS Investment Management
California
-$12.6M
3
PMAM
Picton Mahoney Asset Management
Ontario, Canada
-$10.6M
4
FC
Fairpointe Capital
Illinois
-$10.4M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$9.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
Boston Partners
101
Boston Partners
Massachusetts
$2.93M -$135K -2,152 -4%
HPCM
102
High Pointe Capital Management
Illinois
$2.89M -$357K -5,700 -11%
FLPIM
103
F.L. Putnam Investment Management
Massachusetts
$2.86M +$2.82M +44,930 New
PCM
104
Piermont Capital Management
Missouri
$2.85M -$35.7K -570 -1%
Los Angeles Capital Management
105
Los Angeles Capital Management
California
$2.77M -$34.8K -555 -1%
GCP
106
GSA Capital Partners
United Kingdom
$2.73M +$968K +15,447 +56%
AP
107
AHL Partners
United Kingdom
$2.69M +$2.39M +38,079 +901%
TPSF
108
Texas Permanent School Fund
Texas
$2.69M -$5.45K -87 -0.2%
Calamos Advisors
109
Calamos Advisors
Illinois
$2.67M -$15.7K -250 -0.6%
FQ
110
First Quadrant
California
$2.61M – – –
MLICM
111
Metropolitan Life Insurance Company (MetLife)
New York
$2.6M +$36.9K +588 +1%
AAM
112
Advisors Asset Management
Colorado
$2.55M +$494K +7,886 +25%
PA
113
Profund Advisors
Maryland
$2.49M +$346K +5,515 +16%
SAM
114
Shell Asset Management
Netherlands
$2.43M – – –
State of Wisconsin Investment Board
115
State of Wisconsin Investment Board
Wisconsin
$2.4M +$138K +2,200 +6%
SFM
116
Systematic Financial Management
New Jersey
$2.37M -$179K -2,860 -7%
CAM
117
ClariVest Asset Management
California
$2.35M -$324K -5,174 -12%
TA
118
Teachers Advisors
New York
$2.33M +$233K +3,714 +11%
Thrivent Financial for Lutherans
119
Thrivent Financial for Lutherans
Minnesota
$2.27M -$150K -2,400 -6%
GT
120
Glenmede Trust
Pennsylvania
$2.2M – – –
AllianceBernstein
121
AllianceBernstein
Tennessee
$2.16M -$18.8K -300 -0.9%
TC
122
TFS Capital
Pennsylvania
$2.1M -$2.02M -32,173 -49%
OCM
123
Olstein Capital Management
New York
$2.04M -$5.58M -89,000 -74%
SEI Investments
124
SEI Investments
Pennsylvania
$1.97M +$1.94M +30,941 New
UBS Group
125
UBS Group
Switzerland
$1.92M +$1.89M +30,102 New
3 4
5
6 7

CRL Hedge Fund Activity: Q4 2014 in Review

252 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q4 2014, worth a combined $3.49B — up 26% from $2.77B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new CRL positions and 24 closed out — a net gain of 2 holders — while 77 added to existing stakes and 109 trimmed.

The largest buyer was First Trust Advisors, adding an estimated $77.7M. The largest seller was Wellington Management Group, cutting an estimated $16.6M.

  • 252 institutional investors held Charles River Laboratories (CRL) as of Q4 2014, down from 255 in Q3 2014.
  • Funds reported $3.49B of Charles River Laboratories stock for Q4 2014, up 26% quarter-over-quarter.
  • 26 funds opened new Charles River Laboratories positions in Q4 2014 and 24 closed out, a net change of +2 holders.
  • The largest Charles River Laboratories buyer in Q4 2014 was First Trust Advisors, an estimated $77.7M added.
  • The largest Charles River Laboratories seller in Q4 2014 was Wellington Management Group, an estimated $16.6M sold.

Based on aggregated 13F filings for Q4 2014.